ArticleEMBO molecular medicine2019

Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination.

Fabien Binamé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.